BIOANALYTICAL SYSTEMS INC

BIOANALYTICAL SYSTEMS INC

Previous company name

Name change date

Company Overview
Bioanalytical Systems Inc (BASi) is a leading manufacturer of specialized instrumentation and accessories for liquid chromatography, in vivo sampling (whole blood, plasma, microdialysis and ultrafiltration), electrochemistry, and veterinary medicine. The company’s corporate headquarters is located in West Lafayette, Indiana.
The company is engaged in the development of drugs for contract research services and unique products for the biotechnology, pharmaceutical and medical device industries. Its products and services is used in drug metabolism research, pharmacokinetics studies, pharmacology, toxicology, pharmaceutical product analysis, stability program support and veterinary health.
BASi’s scientific instruments include In In Vitro Diagnostic Products, In Vivo Sampling Products (whole blood and membrane sampling), Electrochemical Analyzers, Liquid Chromatographs, and Veterinary Physiological Monitors.
The company’s laboratories are located in the USA and UK and a partner laboratory in France with Biotec Centre.
BASi is a member of the Pharmaceutical Industry Contract Research Alliance, a consortium of small to mid-sized specialized service companies that provide high quality services throughout the drug development process.
Business Summary
Bioanalytical Systems, Inc. and its subsidiaries are engaged in research services and other services related to pharmaceutical development. The Company also manufactures scientific instruments for medical research, which it sells with related software for use in industrial, governmental and academic laboratories. The Company operates in two business segments: contract research services and research products. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The Company designs, develops, manufactures and markets in vivo sampling systems and accessories, including disposables, training and systems qualification; physiology monitoring tools, and liquid chromatography and electrochemistry instruments platforms.
Description and history
Bioanalytical Systems, Inc. and its subsidiaries are engaged in research services and other services related to pharmaceutical development. The Company also manufactures scientific instruments for medical research, which it sells with related software for use in industrial, governmental and academic laboratories. The Company provides contract drug development services and research equipment to global pharmaceutical, medical research, and biotechnology companies and institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The Company operates in two business segments: contract research services and research products. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The Company designs, develops, manufactures and markets in vivo sampling systems and accessories, including disposables, training and systems qualification; physiology monitoring tools, and liquid chromatography and electrochemistry instruments platforms.

Contract Research Services

The contract research services provide product characterization, method development and validation; bioanalytical testing; stability testing; in vivo pharmacology, and preclinical and pathology services. In the product characterization, method development and validation services, the Company provides analytical methods to determine potency, purity, chemical composition, structure and physical properties of a compound. In the bioanalytical testing, the Company analyzes specimens from preclinical and clinical trials to measure drug and metabolite concentrations in biological matrices. In the stability testing, the Company tests stability of drug substances and formulated drug products and maintain secure storage facilities in West Lafayette, Indiana to establish and confirm product purity, potency and shelf life.

In the in vivo pharmacology, the Company provides preclinical in vivo sampling services for the continuous monitoring of chemical changes in life, in particular, how a drug enters, travels through and is metabolized in living systems. In the preclinical and pathology services, the Company provides pharmacokinetic and safety testing in studies ranging from acute safety monitoring of drugs and medical devices to chronic, multi-year oncogenicity studies in its Evansville, Indiana site.

Research Products

The Company focuses its products business on expediting preclinical screening of developmental drugs. The Company offers three product lines: analytical products, in vivo sampling products and vetronic’s products. The analytical products consist of the Company’s liquid chromatographic and electrochemical instruments with associated accessories. The in vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments. These are used by pharmaceutical researchers to dose animals and collect biological samples (blood, bile, urine, microdialysate, feces or any bio-fluid) from the animals. The line also includes miniaturized in vivo sampling devices sold to drug developers and medical research centers to assist in the study of a number of medical conditions, including stroke, depression, Alzheimer’s and Parkinson’s diseases, diabetes and osteoporosis. The Vetronics’ products consist of instruments and related software to monitor and diagnose cardiac function (electro-cardiogram) and measure other vital physiological parameters primarily in cats and dogs in veterinary clinics.

The Company competes with Covance, Inc., Pharmaceutical Product Development, Inc., Charles River Laboratories, Inc., Parexel and MDS Health Group Ltd.

Business Line
Engaged in the development of drugs for contract research services and unique products for the biotechnology, pharmaceutical and medical device industries
Subsidiary
BAS EVANSVILLE INC.
Advisor
CROWE HORWATH LLP
IPO date
11/1997
US SIC Code
8731
Company Address
2701, Kent Avenue

City province or state postal code
47906, WEST LAFAYETTE, IN
Phone: +1 765 463 4527
Fax: +1 765 463 5297
Country address: UNITED STATES OF AMERICA
Website url: www.bioanalytical.com